Shares of Mankind Pharma Ltd were trading with modest gain on signing an exclusive in-licensing and marketing agreement with China’s Chongqing Chenan Biopharmaceutical Co. Ltd. for the commercialisation of two insulin analogues in India. The agreement covers Insulin Degludec and an Insulin Degludec + Aspart combination, strengthening Mankind Pharma’s presence... The post Mankind Pharma Signs Exclusive Deal for Two Insulin Analogues appeared first on Equitypandit .
Shares of Mankind Pharma Ltd were trading with modest gain on signing an exclusive in-licensing and marketing agreement with China’s Chongqing Chenan Biopharmaceutical Co. Ltd. for the commercialisation of two insulin analogues in India. The agreement covers Insulin Degludec and an Insulin Degludec + Aspart combination, strengthening Mankind Pharma’s presence... The post Mankind Pharma Signs Exclusive Deal for Two Insulin Analogues appeared first on Equitypandit .This article was originally published by Equitypandit.
Read Full Story on Source Site →
